Meeting
2016 Genitourinary Cancers Symposium
Outcomes of second targeted therapy in metastatic renal carcinoma: A retrospective chart review in the EU.
Authors
Daniel Yick Chin Heng
Tom Baker Cancer Center, University of Calgary, Calgary, AB, Canada
Daniel Yick Chin Heng , Jinhee Park , James E. Signorovitch , Hongbo Yang , Jinlin Song , Dony Patel , Chinjune Lin , Thomas Powles
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Renal Cell Cancer
Citation
J Clin Oncol 34, 2016 (suppl 2S; abstr 558)
DOI
10.1200/jco.2016.34.2_suppl.558
Abstract #
558
Poster Bd #
F19
Abstract Disclosures
Similar Posters
Poster
2017 Genitourinary Cancers Symposium
Fourth-line targeted therapy in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC).
First Author: Igor Stukalin
Poster
2021 Genitourinary Cancers Symposium
Cabozantinib (Cabo) beyond progression improves survival in advanced renal cell carcinoma patients: The CABEYOND study (Meet-Uro 21).
First Author: Giuseppe Procopio
Poster
2016 ASCO Annual Meeting
Association of high cost sharing and target therapy initiation among Medicare patients with metastatic renal cell carcinoma.
First Author: Pengxiang Li
Poster
2015 Genitourinary Cancers Symposium
Third-line therapy in metastatic renal cell carcinoma: Results from the International mRCC Database Consortium.
First Author: Daniel Yick Chin Heng